Irish healthcare body increases drugs wholesale mark-ups, following Court ruling
This article was originally published in RAJ Devices
Executive Summary
Following a High Court Ruling issued in September 2008, the Irish Health Services Executive (HSE) has upgraded the wholesale mark-up, which it pays to pharmacies for reimbursed medicines, from 8% to the previous level of 17.66%. The reinstated wholesale margin will apply to medicines dispensed on or after 1 October 2008.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.